O75376

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession NCOR1_HUMAN; O75376;
Entrez ID 9611
GenBank Protein ID NM_001190438.1; NM_001190440.1; NM_006311.3; XM_011524086.2;
GenBank Nucleotide ID NP_001177367.1; NP_001177369.1; NP_006302.2; XP_011522388.1;
Protein Name Nuclear receptor corepressor 1 (N-CoR) (N-CoR1)
Gene Name NCOR1; KIAA1047
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionMediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6.
Sequence
(Fasta)
MSSSGYPPNQ GAFSTEQSRY PPHSVQYTFP NTRHQQEFAV PDYRSSHLEV SQASQLLQQQ 60
QQQQLRRRPS LLSEFHPGSD RPQERRTSYE PFHPGPSPVD HDSLESKRPR LEQVSDSHFQ 120
RVSAAVLPLV HPLPEGLRAS ADAKKDPAFG GKHEAPSSPI SGQPCGDDQN ASPSKLSKEE 180
LIQSMDRVDR EIAKVEQQIL KLKKKQQQLE EEAAKPPEPE KPVSPPPVEQ KHRSIVQIIY 240
DENRKKAEEA HKIFEGLGPK VELPLYNQPS DTKVYHENIK TNQVMRKKLI LFFKRRNHAR 300
KQREQKICQR YDQLMEAWEK KVDRIENNPR RKAKESKTRE YYEKQFPEIR KQREQQERFQ 360
RVGQRGAGLS ATIARSEHEI SEIIDGLSEQ ENNEKQMRQL SVIPPMMFDA EQRRVKFINM 420
NGLMEDPMKV YKDRQFMNVW TDHEKEIFKD KFIQHPKNFG LIASYLERKS VPDCVLYYYL 480
TKKNENYKAL VRRNYGKRRG RNQQIARPSQ EEKVEEKEED KAEKTEKKEE EKKDEEEKDE 540
KEDSKENTKE KDKIDGTAEE TEEREQATPR GRKTANSQGR RKGRITRSMT NEAAAASAAA 600
AAATEEPPPP LPPPPEPIST EPVETSRWTE EEMEVAKKGL VEHGRNWAAI AKMVGTKSEA 660
QCKNFYFNYK RRHNLDNLLQ QHKQKTSRKP REERDVSQCE SVASTVSAQE DEDIEASNEE 720
ENPEDSEVEA VKPSEDSPEN ATSRGNTEPA VELEPTTETA PSTSPSLAVP STKPAEDESV 780
ETQVNDSISA ETAEQMDVDQ QEHSAEEGSV CDPPPATKAD SVDVEVRVPE NHASKVEGDN 840
TKERDLDRAS EKVEPRDEDL VVAQQINAQR PEPQSDNDSS ATCSADEDVD GEPERQRMFP 900
MDSKPSLLNP TGSILVSSPL KPNPLDLPQL QHRAAVIPPM VSCTPCNIPI GTPVSGYALY 960
QRHIKAMHES ALLEEQRQRQ EQIDLECRSS TSPCGTSKSP NREWEVLQPA PHQVITNLPE 1020
GVRLPTTRPT RPPPPLIPSS KTTVASEKPS FIMGGSISQG TPGTYLTSHN QASYTQETPK 1080
PSVGSISLGL PRQQESAKSA TLPYIKQEEF SPRSQNSQPE GLLVRAQHEG VVRGTAGAIQ 1140
EGSITRGTPT SKISVESIPS LRGSITQGTP ALPQTGIPTE ALVKGSISRM PIEDSSPEKG 1200
REEAASKGHV IYEGKSGHIL SYDNIKNARE GTRSPRTAHE ISLKRSYESV EGNIKQGMSM 1260
RESPVSAPLE GLICRALPRG SPHSDLKERT VLSGSIMQGT PRATTESFED GLKYPKQIKR 1320
ESPPIRAFEG AITKGKPYDG ITTIKEMGRS IHEIPRQDIL TQESRKTPEV VQSTRPIIEG 1380
SISQGTPIKF DNNSGQSAIK HNVKSLITGP SKLSRGMPPL EIVPENIKVV ERGKYEDVKA 1440
GETVRSRHTS VVSSGPSVLR STLHEAPKAQ LSPGIYDDTS ARRTPVSYQN TMSRGSPMMN 1500
RTSDVTISSN KSTNHERKST LTPTQRESIP AKSPVPGVDP VVSHSPFDPH HRGSTAGEVY 1560
RSHLPTHLDP AMPFHRALDP AAAAYLFQRQ LSPTPGYPSQ YQLYAMENTR QTILNDYITS 1620
QQMQVNLRPD VARGLSPREQ PLGLPYPATR GIIDLTNMPP TILVPHPGGT STPPMDRITY 1680
IPGTQITFPP RPYNSASMSP GHPTHLAAAA SAERERERER EKERERERIA AASSDLYLRP 1740
GSEQPGRPGS HGYVRSPSPS VRTQETMLQQ RPSVFQGTNG TSVITPLDPT AQLRIMPLPA 1800
GGPSISQGLP ASRYNTAADA LAALVDAAAS APQMDVSKTK ESKHEAARLE ENLRSRSAAV 1860
SEQQQLEQKT LEVEKRSVQC LYTSSAFPSG KPQPHSSVVY SEAGKDKGPP PKSRYEEELR 1920
TRGKTTITAA NFIDVIITRQ IASDKDARER GSQSSDSSSS LSSHRYETPS DAIEVISPAS 1980
SPAPPQEKLQ TYQPEVVKAN QAENDPTRQY EGPLHHYRPQ QESPSPQQQL PPSSQAEGMG 2040
QVPRTHRLIT LADHICQIIT QDFARNQVSS QTPQQPPTST FQNSPSALVS TPVRTKTSNR 2100
YSPESQAQSV HHQRPGSRVS PENLVDKSRG SRPGKSPERS HVSSEPYEPI SPPQVPVVHE 2160
KQDSLLLLSQ RGAEPAEQRN DARSPGSISY LPSFFTKLEN TSPMVKSKKQ EIFRKLNSSG 2220
GGDSDMAAAQ PGTEIFNLPA VTTSGSVSSR GHSFADPASN LGLEDIIRKA LMGSFDDKVE 2280
DHGVVMSQPM GVVPGTANTS VVTSGETRRE EGDPSPHSGG VCKPKLISKS NSRKSKSPIP 2340
GQGYLGTERP SSVSSVHSEG DYHRQTPGWA WEDRPSSTGS TQFPYNPLTM RMLSSTPPTP 2400
IACAPSAVNQ AAPHQQNRIW EREPAPLLSA QYETLSDSDD 2441

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1Serine PhosphorylationProstate cancer/carcinoma/adenocarcinomaPC-3 cell lineUS243623669876
[Reference]: In this study, we report that both CK2 activity and CK2-mediated NCoR phosphorylation are significantly elevated in the androgen-independent prostate cancer cell line DU145 and PC-3 compared with RWPE1 and LNCaP cells

※ Disease Cross-ref Annotation

DatabaseAnnotation
Cancer Gene Census
breast
CTD (Curated)
(count: 6)
MESH:D001943 ; Breast Neoplasms
MESH:D002295 ; Carcinoma, Transitional Cell
MESH:D004715 ; Endometriosis
MESH:D005909 ; Glioblastoma
MESH:D008113 ; Liver Neoplasms
MESH:D001749 ; Urinary Bladder Neoplasms
GWASdb
(count: 15)
(view all)
rs7224403; Type 2 diabetes; type 2 diabetes mellitus
rs8067494; Type 2 diabetes; type 2 diabetes mellitus
rs8079698; Type 2 diabetes; type 2 diabetes mellitus
rs3760296; Type 2 diabetes; type 2 diabetes mellitus
rs1073093; Type 2 diabetes; type 2 diabetes mellitus
rs1073094; Type 2 diabetes; type 2 diabetes mellitus

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 184)
(view all)
106       VDHDSLESKRPRLEQ     dbPAF
1061      GGSISQGTPGTYLTS     dbPAF
1111      YIKQEEFSPRSQNSQ     dbPAF
1117      FSPRSQNSQPEGLLV     dbPAF
1143      AGAIQEGSITRGTPT     dbPAF
1145      AIQEGSITRGTPTSK     dbPAF
Acetylation
(count: 15)
(view all)
1048      KTTVASEKPSFIMGG     PLMD
1313      ESFEDGLKYPKQIKR     PLMD
1334      AFEGAITKGKPYDGI     PLMD
1336      EGAITKGKPYDGITT     PLMD
1345      YDGITTIKEMGRSIH     PLMD
1400      NSGQSAIKHNVKSLI     PLMD
Ubiquitination
(count: 14)
(view all)
1184      IPTEALVKGSISRMP     PLMD
1412      SLITGPSKLSRGMPP     PLMD
1511      DVTISSNKSTNHERK     PLMD
1838      APQMDVSKTKESKHE     PLMD
1840      QMDVSKTKESKHEAA     PLMD
1869      EQQQLEQKTLEVEKR     PLMD
Sumoylation
(count: 15)
(view all)
1106      SATLPYIKQEEFSPR     PLMD
1184      IPTEALVKGSISRMP     PLMD
1207      GREEAASKGHVIYEG     PLMD
1215      GHVIYEGKSGHILSY     PLMD
1226      ILSYDNIKNAREGTR     PLMD
1319      LKYPKQIKRESPPIR     PLMD
Glycation
(count: 1)
1255      ESVEGNIKQGMSMRE     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource
B4DUN1O75376HPRD; MINT
B4DYX9O75376IntAct
E9PFV2O75376IntAct
F5H1U8O75376HPRD
H0YBT0O75376IntAct
O14646O75376HPRD
O15379O75376HPRD; IntAct; MINT
O43439O75376HPRD
O60907O75376HPRD
O75376O75376HPRD
O75376O75446HPRD
O75376P03372HPRD; IntAct
O75376P04150HPRD
O75376P06454HPRD
O75376P08047HPRD
O75376P10242IntAct
O75376P10244HPRD
O75376P10275HPRD
O75376P10276HPRD; DIP; IntAct
O75376P10827HPRD
O75376P10828HPRD;IntAct
O75376P12755HPRD; IntAct
O75376P12757HPRD; MINT
O75376P14921HPRD
O75376P15036HPRD
O75376P20393HPRD; DIP
O75376P29590HPRD
O75376P35232HPRD
O75376P35609HPRD
O75376P37231HPRD
O75376P41182HPRD; DIP
O75376P42858HPRD
O75376P51532IntAct
O75376P54253HPRD; IntAct; MINT
O75376P55055HPRD
O75376Q03181HPRD
O75376Q05516HPRD; DIP
O75376Q06330HPRD
O75376Q06455HPRD; DIP
O75376Q07869HPRD
O75376Q12824IntAct
O75376Q13133HPRD
O75376Q13227HPRD
O75376Q13263IntAct
O75376Q13901HPRD
O75376Q14995HPRD
O75376Q15326HPRD; MINT
O75376Q15393IntAct
O75376Q15406HPRD
O75376Q15459IntAct
O75376Q15916DIP
O75376Q16342HPRD
O75376Q16576MINT
O75376Q6MZP7IntAct
O75376Q6ZRS2IntAct
O75376Q7L2E3HPRD; MINT
O75376Q86T24HPRD
O75376Q86Y13HPRD
O75376Q8TAQ2IntAct
O75376Q92731HPRD
O75376Q92922IntAct
O75376Q96EB6IntAct
O75376Q96T58HPRD
O75376Q99081DIP
O75376Q99933MINT
O75376Q9BZK7HPRD; IntAct
O75376Q9NNW7HPRD
O75376Q9UBP5HPRD
O75376Q9UBX0HPRD
O75376Q9UHI6HPRD
O75376Q9UI36IntAct;HPRD
O75376Q9UKV0IntAct;HPRD
O75376Q9UQL6HPRD
O75376Q9Y5X4HPRD; MINT
O75376Q9Y618IntAct